EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-γ-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma

American Journal of Pathology

Volumn 184, Issue 4, 2014, Pages 1185-1197

  Huang, Wei Ting ^a   Lin, Chung Wu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GAMMA INTERFERON; LUCIFERASE; MICRORNA; MICRORNA BART20 5P; MICRORNA BART8; MICRORNA LET7A; PROTEIN P53; RENILLA LUCIFERIN 2 MONOOXYGENASE; STAT1 PROTEIN; UNCLASSIFIED DRUG; STAT1 PROTEIN, HUMAN; TRANSCRIPTOME;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; NK T CELL LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION; WESTERN BLOTTING; WILD TYPE; COMPLICATION; DISEASE COURSE; DNA MICROARRAY; GENETICS; IMMUNOLOGY; LYMPHOMA; NATURAL KILLER CELL; NOSE TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY;

BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOMA; MICRORNAS; NOSE NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTOME;

EID: 84897895952     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.12.024     Document Type: Article

References (50)

1. T.C. Lin, S.U. Chen, Y.F. Chen, Y.C. Chang, and C.W. Lin Intramucosal variant of nasal natural killer (NK)/T cell lymphoma has a better survival than does invasive variant: implication on loss of E26 transformation-specific sequence 1 (ETS-1) and T-box expressed in T cells (T-bet) with invasion Histopathology 60 2012 287 295
2. H.A. Young, and J.H. Bream IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications Curr Top Microbiol Immunol 316 2007 97 117
3. L.L. Lanier Evolutionary struggles between NK cells and viruses Nat Rev Immunol 8 2008 259 268
4. N.C. Reich STAT dynamics Cytokine Growth Factor Rev 18 2007 511 518
5. H.S. Kim, and M.S. Lee STAT1 as a key modulator of cell death Cell Signal 19 2007 454 465
6. J. Vilcek Boosting p53 with interferon and viruses Nat Immunol 4 2003 825 826
7. P.A. Townsend, T.M. Scarabelli, S.M. Davidson, R.A. Knight, D.S. Latchman, and A. Stephanou STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis J Biol Chem 279 2004 5811 5820
8. A.A. Bhinge, J. Kim, G.M. Euskirchen, M. Snyder, and V.R. Iyer Mapping the chromosomal targets of STAT1 by sequence tag analysis of genomic enrichment (STAGE) Genome Res 17 2007 910 916
9. D.H. Kaplan, V. Shankaran, A.S. Dighe, E. Stockert, M. Aguet, L.J. Old, and R.D. Schreiber Demonstration of an interferon gamma-dependent tumor surveillance system in immune competent mice Proc Natl Acad Sci USA 95 1998 7556 7561
10. C. Porta, R. Hadj-Slimane, M. Nejmeddine, M. Pampin, M.G. Tovey, L. Espert, S. Alvarez, and M.K. Chelbi-Alix Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively Oncogene 24 2005 605 615
11. M.P. Gil, E. Bohn, A.K. O'Guin, C.V. Ramana, B. Levine, G.R. Stark, H.W. Virgin, and R.D. Schreiber Biologic consequences of Stat1-independent IFN signaling Proc Natl Acad Sci USA 98 2001 6680 6685
12. C.V. Ramana, M.P. Gil, Y. Han, R.M. Ransohoff, R.D. Schreiber, and G.R. Stark Stat1-independent regulation of gene expression in response to IFN-gamma Proc Natl Acad Sci USA 98 2001 6674 6679
13. M. Sajish, Q. Zhou, S. Kishi, D.M. Valdez Jr., M. Kapoor, M. Guo, S. Lee, S. Kim, X.L. Yang, and P. Schimmel Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-gamma and p53 signaling Nat Chem Biol 8 2012 547 554
14. M.M. Goodwin, S. Canny, A. Steed, and H.W. Virgin Murine gammaherpesvirus 68 has evolved gamma interferon and Stat1-repressible promoters for the lytic switch gene 50 J Virol 84 2010 3711 3717
15. L. Quintanilla-Martinez, M. Kremer, G. Keller, M. Nathrath, A. Gamboa-Dominguez, A. Meneses, L. Luna-Contreras, A. Cabras, H. Hoefler, A. Mohar, and F. Fend p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease Am J Pathol 159 2001 2095 2105
16. S. Barth, G. Meister, and F.A. Grässer EBV-encoded miRNAs Biochim Biophys Acta 1809 2011 631 640
17. D. Nachmani, N. Stern-Ginossar, R. Sarid, and O. Mandelboim Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells Cell Host Microbe 5 2009 376 385
18. E.Y. Choy, K.L. Siu, K.H. Kok, R.W. Lung, C.M. Tsang, K.F. To, D.L. Kwong, S.W. Tsao, and D.Y. Jin An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival J Exp Med 205 2008 2551 2560
19. T. Xia, A. O'Hara, I. Araujo, J. Barreto, E. Carvalho, J.B. Sapucaia, J.C. Ramos, E. Luz, C. Pedroso, M. Manrique, N.L. Toomey, C. Brites, D.P. Dittmer, and W.J. Harrington Jr. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 Cancer Res 68 2008 1436 1442
20. T.C. Lin, T.Y. Liu, S.M. Hsu, and C.W. Lin The EBV-encoded miR-BART20-5p inhibits T-bet with secondary suppression of p53 in invasive nasal NK-cell lymphoma Am J Pathol 182 2013 1865 1875
21. D.F. Steiner, M.F. Thomas, J.K. Hu, Z. Yang, J.E. Babiarz, C.D. Allen, M. Matloubian, R. Blelloch, and K.M. Ansel MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells Immunity 35 2011 169 181
22. F. Ma, S. Xu, X. Liu, Q. Zhang, X. Xu, M. Liu, M. Hua, N. Li, H. Yao, and X. Cao The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ Nat Immunol 12 2011 861 869
23. T.Y. Liu, S.U. Chen, S.H. Kuo, A.L. Cheng, and C.W. Lin E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response Mod Pathol 23 2010 1507 1517
24. A. Sturn, J. Quackenbush, and Z. Trajanoski Genesis: cluster analysis of microarray data Bioinformatics 18 2002 207 208
25. G.K. Geiss, R.E. Bumgarner, B. Birditt, T. Dahl, N. Dowidar, D.L. Dunaway, H.P. Fell, S. Ferree, R.D. George, T. Grogan, J.J. James, M. Maysuria, J.D. Mitton, P. Oliveri, J.L. Osborn, T. Peng, A.L. Ratcliffe, P.J. Webster, E.H. Davidson, L. Hood, and K. Dimitrov Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 2008 317 325
26. M.A. Vladislav Multiplexed measurements of gene signatures in different analytes using the NanoString nCounter assay system BMC Res Notes 2 2009 80
27. M.M. Kulkarni Digital multiplexed gene expression analysis using the NanoString nCounter system Curr Protoc Mol Biol Suppl 94 2011 25B.10.1-25B.10.17
28. J. Krüger, and M. Rehmsmeier RNAhybrid: microRNA target prediction easy, fast and flexible Nucleic Acids Res 34 Web Server issue 2006 W451 W454
29. F. Schaufele, G.M. Gilmartin, W. Bannwarth, and M.L. Birnstiel Compensatory mutations suggest that base-pairing with a small nuclear RNA is required to form the 3′ end of H3 messenger RNA Nature 323 1986 777 781
30. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
31. C.D. Johnson, A. Esquela-Kerscher, G. Stefani, M. Byrom, K. Kelnar, D. Ovcharenko, M. Wilson, X. Wang, J. Shelton, J. Shingara, L. Chin, D. Brown, and F.J. Slack The let-7 microRNA represses cell proliferation pathways in human cells Cancer Res 67 2007 7713 7722
32. V.S. Nair, L.S. Maeda, and J.P. Ioannidis Clinical outcome prediction by microRNAs in human cancer: a systematic review J Natl Cancer Inst 104 2012 528 540
33. T. Decker, P. Kovarik, and A. Meinke GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression J Interferon Cytokine Res 17 1997 121 134
34. J.L. Kutok, and F. Wang Spectrum of Epstein-Barr virus-associated diseases Annu Rev Pathol 1 2006 375 404
35. H.G. Drexler, and Y. Matsuo Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma Leukemia 14 2000 777 782
36. L. Malmgaard Induction and regulation of IFNs during viral infections J Interferon Cytokine Res 24 2004 439 454
37. R.G. Jenner, M.J. Townsend, I. Jackson, K. Sun, R.D. Bouwman, R.A. Young, L.H. Glimcher, and G.M. Lord The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes Proc Natl Acad Sci USA 106 2009 17876 17881
38. S.J. Szabo, S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman, and L.H. Glimcher A novel transcription factor, T-bet, directs Th1 lineage commitment Cell 100 2000 655 669
39. Y. Yang, J.C. Ochando, J.S. Bromberg, and Y. Ding Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNgamma/Stat1 signals Blood 110 2007 2494 2500
40. S.H. Beachy, M. Onozawa, Y.J. Chung, C. Slape, S. Bilke, P. Francis, M. Pineda, R.L. Walker, P. Meltzer, and P.D. Aplan Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma Blood 120 2012 1048 1059
41. K.S. Khabar, and H.A. Young Post-transcriptional control of the interferon system Biochimie 89 2007 761 769
42. Y. Ben-Asouli, Y. Banai, Y. Pel-Or, A. Shir, and R. Kaempfer Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR Cell 108 2002 221 232
43. P. Qi, J.X. Han, Y.Q. Lu, C. Wang, and F.F. Bu Virus-encoded microRNAs: future therapeutic targets? Cell Mol Immunol 3 2006 411 419
44. C.J. Brown, S. Lain, C.S. Verma, A.R. Fersht, and D.P. Lane Awakening guardian angels: drugging the p53 pathway Nat Rev Cancer 9 2009 862 873
45. D.P. Lane, C.F. Cheok, and S. Lain p53-based cancer therapy Cold Spring Harb Perspect Biol 2 2010 a001222
46. G.P. Dunn, C.M. Koebel, and R.D. Schreiber Interferons, immunity and cancer immunoediting Nat Rev Immunol 6 2006 836 848
47. N. Raab-Traub Novel mechanisms of EBV-induced oncogenesis Curr Opin Virol 2 2012 453 458
48. L.C. Spender, and G.J. Inman Inhibition of germinal centre apoptotic programmes by Epstein-Barr virus Adv Hematol 2011 2011 829525 829535
49. D. Vereide, and B. Sugden Insights into the evolution of lymphomas induced by Epstein-Barr virus Adv Cancer Res 108 2010 1 19
50. Y. Sato, T. Kamura, N. Shirata, T. Murata, A. Kudoh, S. Iwahori, Y. Nishiyama, and T. Tsurumi Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex PLoS Pathog 5 2009 e1000530